# Kristine Yaffe

Populaarseimad podcastide jaod
Uuendatud:

The weekly roundup - December 9th

It’s time for the weekly roundup again. This week we spoke to a research scientist at the Lawrence Berkeley National Laboratory about how the amount of carbon dioxide that trees and plants have been grabbing from the atmosphere has increased over the years. Trevor Keenan says explains that plants h…

Episode 5 - Dr. Dale Bredesen and Dr. Craig Tanio on the Prevention of Cognitive Decline

Dale E. Bredesen MD, is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. In this episode, Dale, Craig and Jacob discuss Alzheimer's disease, multimodal approaches to neurodegeneration, new therapeutics for Alzheimer's, and his newe…

Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia

Interview with Kristine Yaffe, MD, author of Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia

How are early adulthood depression and dementia associated?

How are early adulthood depression and dementia associated? In this episode, I feature a paper by Brenowitz and colleagues who used innovative statistical methods to discover that having depression in your 20s-40s increases the odds of suffering from dementia later in life. Hence, they highlight t…

Trending With Impact: Cognitive Decline Predicted from Middle-Age

Listen to a blog summary of the research paper selected as the cover for Volume 14, Issue 4 of Aging (Aging-US): Aging seems nearly synonymous with brewing cognitive decline, but does it have to be? There are interventions that may help preserve cognitive function with age, however, the first orde…

FDA Poised to Approve New Alzheimer's Drug

The U.S. Food and Drug Administration is expected to approve the experimental dementia drug Lecanemab as soon as this week, a move embraced by Alzheimer's disease researchers after trials showed it slowed the progression of the disease in some patients with mild cognitive impairment. The new potent…

Prevention of Dementia: Kristine Yaffe

We've had multiple GeriPal episodes about treatments for dementia, including aducanumab (here, here, and here) and lecanemab (here). As today's guest, Kristine Yaffe notes, part of the reason for that emphasis is that in the US we prioritize treatment, whereas other countries are ahead of us in p…

Dementia Risk and Disadvantaged Neighborhoods

Interview with Kristine Yaffe, MD, author of Dementia Risk and Disadvantaged Neighborhoods. Hosted by Cynthia E. Armand, MD. Related Content: Dementia Risk and Disadvantaged Neighborhoods

JAMA Neurology : Dementia Risk and Disadvantaged Neighborhoods

Interview with Kristine Yaffe, MD, author of Dementia Risk and Disadvantaged Neighborhoods. Hosted by Cynthia E. Armand, MD. Related Content: Dementia Risk and Disadvantaged Neighborhoods

From Alzheimer's Association International Conference 2026. With Lucia Crivelli, Paulo Caramelli, Heather Snyder, Maria Carrillo, Juan Fortea, Kristine Yaffe and Lon Schneider

In this episode, The Lancet reports from the 2026 Alzheimer’s Association International Conference at ExCeL London, which brought together more than 10,000 attendees from 111 countries. Neurology Editor, Beatriz Gómez Pérez-Nievas speaks with LatAm FINGERS authors right after the study’s launch, a…